Back
Recursion Pharmaceuticals Stock Predictions
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
RXRX
Recursion Pharmaceuticals
Last Price:
$4.11
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Recursion Pharmaceuticals Stock Forecast
-
Is Recursion Pharmaceuticals Stock Undervalued?The current Recursion Pharmaceuticals [RXRX] share price is $4.24. The Score for RXRX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Recursion Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Recursion Pharmaceuticals Stock Rating
Data Unavailable
Recursion Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
recursion.com
52-Week Data
52-Week High:
12.36
52-Week Low:
4.06
Prediction Charts
Market Cap:
1.7B
Price in USD:
4.24
Volume:
28.1M
Beta:
1.00
Technical Analysis
SMA50:
7.16
SMA100:
7.03
SMA200:
7.11
52-Wk Change:
-51.43%
Stock Predictions
-
Is Recursion Pharmaceuticals stock public?Yes, Recursion Pharmaceuticals is a publicly traded company.
-
What is the Recursion Pharmaceuticals stock quote today?The Recursion Pharmaceuticals stock price is 4.24 USD today.
-
How to buy Recursion Pharmaceuticals stock online?You can buy Recursion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-18 | 6.58 | 6.39 | 6.61 | 6.22 |
| Mar-19 | 6.40 | 6.58 | 6.75 | 6.36 |
| Mar-20 | 6.50 | 6.48 | 6.76 | 6.40 |
| Mar-21 | 6.31 | 6.68 | 6.74 | 6.27 |
| Mar-24 | 6.83 | 6.79 | 6.94 | 6.66 |
| Mar-25 | 6.74 | 6.53 | 6.76 | 6.47 |
| Mar-26 | 6.52 | 6.17 | 6.54 | 6.08 |
| Mar-27 | 6.04 | 5.97 | 6.30 | 5.95 |
| Mar-28 | 5.95 | 5.81 | 6.01 | 5.77 |
| Mar-31 | 5.50 | 5.29 | 5.51 | 5.19 |
| Apr-1 | 5.32 | 5.10 | 5.34 | 5.00 |
| Apr-2 | 4.99 | 5.29 | 5.37 | 4.95 |
| Apr-3 | 4.91 | 4.81 | 5.03 | 4.78 |
| Apr-4 | 4.59 | 4.24 | 4.74 | 4.06 |
Recursion Pharmaceuticals Earnings
Data Unavailable
Recursion Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.17 per share, a decrease this year of $0.10 per share, and an increase next year of $0.25 per share.
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.